Press "Enter" to skip to content

New patent expiration for Organon Sub drug BRIDION

2
Copyright © DrugPatentWatch. Originally published at New patent expiration for Organon Sub drug BRIDION

Annual Drug Patent Expirations for BRIDION
Annual Drug Patent Expirations for BRIDION

Bridion is a drug marketed by Organon Sub Merck and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

Drug patent litigation for BRIDION.

This drug has fifty-four patent family members in thirty countries.

The generic ingredient in BRIDION is sugammadex sodium. One supplier is listed for this compound. Additional details are available on the sugammadex sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Organon Sub drug BRIDION
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions